192 related articles for article (PubMed ID: 28640909)
1. HIV-Tat regulates macrophage gene expression in the context of neuroAIDS.
Carvallo L; Lopez L; Fajardo JE; Jaureguiberry-Bravo M; Fiser A; Berman JW
PLoS One; 2017; 12(6):e0179882. PubMed ID: 28640909
[TBL] [Abstract][Full Text] [Related]
2. Functional impact of HIV-1 Tat on cells of the CNS and its role in HAND.
Marino J; Maubert ME; Mele AR; Spector C; Wigdahl B; Nonnemacher MR
Cell Mol Life Sci; 2020 Dec; 77(24):5079-5099. PubMed ID: 32577796
[TBL] [Abstract][Full Text] [Related]
3. Methamphetamine and HIV-1 Tat down regulate β-catenin signaling: implications for methampetamine abuse and HIV-1 co-morbidity.
Sharma A; Hu XT; Napier TC; Al-Harthi L
J Neuroimmune Pharmacol; 2011 Dec; 6(4):597-607. PubMed ID: 21744004
[TBL] [Abstract][Full Text] [Related]
4. Opiate drug use and the pathophysiology of neuroAIDS.
Hauser KF; Fitting S; Dever SM; Podhaizer EM; Knapp PE
Curr HIV Res; 2012 Jul; 10(5):435-52. PubMed ID: 22591368
[TBL] [Abstract][Full Text] [Related]
5. Common gene-network signature of different neurological disorders and their potential implications to neuroAIDS.
Sagar V; Pilakka-Kanthikeel S; Martinez PC; Atluri VSR; Nair M
PLoS One; 2017; 12(8):e0181642. PubMed ID: 28792504
[TBL] [Abstract][Full Text] [Related]
6. Molecular epigenetics, chromatin, and NeuroAIDS/HIV: immunopathological implications.
Chiappelli F; Shapshak P; Commins D; Singer E; Minagar A; Oluwadara O; Prolo P; Pellionisz AJ
Bioinformation; 2008; 3(1):47-52. PubMed ID: 19052666
[TBL] [Abstract][Full Text] [Related]
7. SI for NeuroAIDS: CNS function and dysfunction when HIV is a chronic disease.
Smith BR; Nath A
Neurosci Lett; 2023 May; 804():137203. PubMed ID: 36972895
[TBL] [Abstract][Full Text] [Related]
8. Molecular epigenetics, chromatin, and NeuroAIDS/HIV: translational implications.
Shapshak P; Chiappelli F; Commins D; Singer E; Levine AJ; Somboonwit C; Minagar A; Pellionisz AJ
Bioinformation; 2008; 3(1):53-7. PubMed ID: 19052667
[TBL] [Abstract][Full Text] [Related]
9. Role of Host Factors on the Regulation of Tat-Mediated HIV-1 Transcription.
Mousseau G; Valente ST
Curr Pharm Des; 2017; 23(28):4079-4090. PubMed ID: 28641539
[TBL] [Abstract][Full Text] [Related]
10. HIV-1 Transcription Inhibitors Increase the Synthesis of Viral Non-Coding RNA that Contribute to Latency.
Akpamagbo YA; DeMarino C; Pleet ML; Schwab A; Rodriguez M; Barclay RA; Sampey G; Iordanskiy S; El-Hage N; Kashanchi F
Curr Pharm Des; 2017; 23(28):4133-4144. PubMed ID: 28641535
[TBL] [Abstract][Full Text] [Related]
11. FoxO4 negatively controls Tat-mediated HIV-1 transcription through the post-transcriptional suppression of Tat encoding mRNA.
Oteiza A; Mechti N
J Gen Virol; 2017 Jul; 98(7):1864-1878. PubMed ID: 28699853
[TBL] [Abstract][Full Text] [Related]
12. HIV and HIV-Tat inhibit LPS-induced IL-27 production in human macrophages by distinct intracellular signaling pathways.
Gajanayaka N; O'Hara S; Konarski Y; Fernandes J; Muthumani K; Kozlowski M; Angel JB; Kumar A
J Leukoc Biol; 2017 Sep; 102(3):925-939. PubMed ID: 28698313
[TBL] [Abstract][Full Text] [Related]
13. Human Immunodeficiency Virus Promotes Mitochondrial Toxicity.
Rozzi SJ; Avdoshina V; Fields JA; Trejo M; Ton HT; Ahern GP; Mocchetti I
Neurotox Res; 2017 Nov; 32(4):723-733. PubMed ID: 28695547
[TBL] [Abstract][Full Text] [Related]
14. Frontline Science: CXCR7 mediates CD14
Veenstra M; Williams DW; Calderon TM; Anastos K; Morgello S; Berman JW
J Leukoc Biol; 2017 Nov; 102(5):1173-1185. PubMed ID: 28754798
[TBL] [Abstract][Full Text] [Related]
15. Progressive Brain Atrophy Despite Persistent Viral Suppression in HIV Patients Older Than 60 Years.
Clifford KM; Samboju V; Cobigo Y; Milanini B; Marx GA; Hellmuth JM; Rosen HJ; Kramer JH; Allen IE; Valcour VG
J Acquir Immune Defic Syndr; 2017 Nov; 76(3):289-297. PubMed ID: 28650401
[TBL] [Abstract][Full Text] [Related]
16. Nucleoside reverse transcriptase inhibitors (NRTIs) induce proinflammatory cytokines in the CNS via Wnt5a signaling.
Wu T; Zhang J; Geng M; Tang SJ; Zhang W; Shu J
Sci Rep; 2017 Jun; 7(1):4117. PubMed ID: 28646196
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Non Canonical HIV-1 Tat Secretion Through the Cellular Na
Agostini S; Ali H; Vardabasso C; Fittipaldi A; Tasciotti E; Cereseto A; Bugatti A; Rusnati M; Lusic M; Giacca M
EBioMedicine; 2017 Jul; 21():170-181. PubMed ID: 28645727
[TBL] [Abstract][Full Text] [Related]
18. BDNF and NGF Expression in Preneoplastic Cervical Disease According to HIV Status.
Sirico A; Simonelli S; Pignatiello S; Fulgione C; Sarno L; Chiuso F; Maruotti GM; Sansone M; Guida M; Insabato L
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445902
[TBL] [Abstract][Full Text] [Related]
19. HIV-1 Transcriptional Activator Tat Inhibits
Anastasopoulou S; Georgakopoulos T; Mouzaki A
Biomolecules; 2023 May; 13(6):. PubMed ID: 37371461
[TBL] [Abstract][Full Text] [Related]
20. Activation of NRF2 blocks HIV replication and apoptosis in macrophages.
Han D; Lu X; Yin W; Fu H; Zhang X; Cheng L; Liu F; Jin C; Tian X; Xie Y; Wu N
Heliyon; 2023 Jan; 9(1):e12575. PubMed ID: 36691556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
